FP
DGX icon

FDO Partners’s Quest Diagnostics DGX Stock Holding History

FDO Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,501
Closed -$640K – 31
2017
Q4 		$640K Sell
6,501
-18,409
-74% -$1.75M 0.55% 71
2017
Q3 		$2.33M Buy
+24,910
New +$2.64M 0.93% 24
2016
Q3 		– Sell
-24,320
Closed -$1.98M – 208
2016
Q2 		$1.98M Buy
24,320
+5,148
+27% +$392K 1.07% 19
2016
Q1 		$1.37M Buy
19,172
+9,766
+104% +$655K 0.89% 26
2015
Q4 		$669K Buy
+9,406
New +$632K 0.38% 112

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FDO Partners's DGX Position: Q1 2018 in Review

FDO Partners sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 6,501 shares — an estimated $640K sold.

FDO Partners first reported a position in DGX in Q4 2015 and held it in 5 quarters. The position peaked at $2.33M in Q3 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • FDO Partners reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • FDO Partners sold 6,501 Quest Diagnostics shares in Q1 2018, an estimated $640K.
  • FDO Partners first reported a position in Quest Diagnostics in Q4 2015 and held it in 5 quarters.
  • FDO Partners's Quest Diagnostics position peaked at $2.33M in Q3 2017.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on FDO Partners's 13F filing for Q1 2018, filed 14 May 2018.